Petri Dish Market Seeking Excellent Growth | Aicor Medical, NEST Biotechnology, Thermo Fisher Scientific



 Petri dishes, also known as cell culture dishes, are ubiquitous glassware used in research and academic laboratories, as well as hospitals, to hold, transfer, and incubate sample substances. A glass petri dish with a lid is used to house an agar culture medium in which bacteria, fungi, and viruses can be grown and researched for various purposes. Microorganisms cannot be culled in a petri dish, but they can be separated from contaminants in the air.

Petri dish is an important piece of labware in practically all research projects, and many infectious diseases are detected using a Petri dish-based culture media. Glass Petri dishes are commonly utilized in numerous scientific activities. However, depending on the sample, polystyrene plastic Petri dishes are also utilized, as some substances are incompatible or react with the glass.

The global The petri dish market was worth US$ 155.2 million in 2017, and it is predicted to grow at a CAGR of 3.6 percent between 2018 and 2026.

The Petri dish market is being driven by increased research and development in the fields of proteomics and genomics, as well as the rising prevalence of infectious diseases and cancer. According to a report issued in 2017 by the International Federation of Pharmaceutical Manufacturers and Associations, the pharmaceutical sector spends US$ 149.8 billion on research and development each year. According to the same source, there are over 7000 substances in the preclinical stage of development.

However, the The Petri dish market has long been in a mature stage, with little innovation and no new product introductions from major companies. Non-culture-based diagnostic tests are rapidly gaining traction in the market, offering faster and more consistent results than culture-based tests that rely on Petri dishes, which is projected to limit market expansion. Furthermore, big research laboratories' adoption of automated liquid handling systems and other lab automation techniques may stifle the petri dish market's growth. Small-scale manufacturers in emerging economies create a fierce rivalry in the petri dish sector, which is also fragmented.

Because chronic diseases such as cancer, cardiovascular disease, and diabetes are so common over the world, research efforts in the industrialized world have shifted to personalized medicine in order to cure them. The market for petri dishes would be bolstered as a result of these efforts to identify effective treatment options for this disease. Personalized medicine employs genomes, proteomics, and cell-based therapies to effectively target disease, increasing the likelihood of a patient's life. Most of these processes, such as cell separation and cell culture growth, require the use of a petri dish.

Aicor Medical, NEST Biotechnology, Thermo Fisher Scientific, Greiner Bio-One, Corning, Phoenix Biomedical, Millipore Sigma, Reinnervate, Narang Medical Limited, Biosigma S.r.l., and Pall Corporation are some of the major companies in the petri dish market.

Comments

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area